THE PREDICTIVE VALUE OF BODY MASS INDEX AND MAYO ADHESIVE PROBABILITY SCORE IN SURGICAL OUTCOMES AND THEIR ROLE IN SURGICAL CONVERSION IN PATIENTS WITH CLINICAL STAGE I RENAL CELL CARCINOMA

被引：0
|
作者：
Tena-Gonzalez Mendez, Gerardo
Gonzalez-Sanchez, Benjamin
Kauffman-Ortega, Christopher
Garza-Gangemi, Adrian M.
Manzanilla-Romero, Hector
Toledo, Vicente
Rodriguez-Covarrubias, Francisco
Gabilondo-Pliego, Bernardo
Gabilondo-Navarro, Fernando
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 203卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP68-20
引用
收藏
页码：E1043 / E1043
页数：1
相关论文
共 50 条
  • [21] Impact of Body Mass Index on Perioperative Complications and Oncologic Outcomes in Patients Undergoing Thermal Ablation for Renal Cell Carcinoma
    Zhou, Wenhui
    Herwald, Sanna E.
    Uppot, Raul N.
    Arellano, Ronald S.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2021, 32 (01) : 33 - 38
  • [22] Impact of body mass index on clinicopathological outcomes in patients with renal cell carcinoma without anorexia-cachexia syndrome
    Watanabe, Daisuke
    Horiguchi, Akio
    Tasaki, Shinsuke
    Kuroda, Kenji
    Sato, Akinori
    Asakuma, Junichi
    Ito, Keiichi
    Asano, Tomohiko
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 8 (01) : 47 - 53
  • [23] Predictive role of preoperative geriatric nutritional risk index for clinical outcomes in surgical gastric cancer patients: A meta-analysis
    Lu, Wei
    Shen, Jian
    Zou, Dehong
    Li, Peng
    Liu, Xiaocong
    Jian, Yi
    FRONTIERS IN SURGERY, 2022, 9
  • [24] Impact of tumor size on the clinical outcomes of patients with Robson Stage I renal cell carcinoma - Author reply
    Kinouchi, T
    Kotake, T
    CANCER, 1999, 86 (03) : 546 - 546
  • [25] Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus
    Lambert, Erica H.
    Pierorazio, Phillip M.
    Shabsigh, Ahmad
    Olsson, Carl A.
    Benson, Mitchell C.
    McKiernan, James M.
    UROLOGY, 2007, 69 (06) : 1054 - 1058
  • [26] Body mass index (BMI) and toxicities and association with clinical outcomes (CO) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (cabo).
    Martini, Dylan J.
    Shabto, Julie M.
    Liu, Yuan
    Carthon, Bradley Curtis
    Speak, Alexandra
    Hitron, Elise
    Russler, Greta
    Caulfield, Sarah
    Ogan, Kenneth
    Harris, Wayne
    Master, Viraj A.
    Kucuk, Omer
    Bilen, Mehmet Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [27] The Impact of Body Mass Index (BMI) on Clinical Outcomes for Patients Receiving Systemic Anti-Cancer Therapies for Advanced Clear Cell Renal Carcinoma
    Greene, John
    Wang, Zhe
    Harris, Benjamin H. L.
    Dodwell, David
    Lord, Simon R.
    CANCER CONTROL, 2025, 32
  • [28] Body mass index and survival in patients with renal cell carcinoma: A clinical-based cohort and meta-analysis
    Choi, Yuni
    Park, Bumsoo
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Choi, Han Yong
    Adami, Hans-Olov
    Lee, Jung Eun
    Lee, Hyun Moo
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (03) : 625 - 634
  • [29] Body Mass Index Alters the Predictive Value of the Neutrophil-to-Lymphocyte Ratio and Systemic Inflammation Response Index in Laryngeal Squamous Cell Carcinoma Patients
    Murad, Luana Dalbem
    Silva, Thays de Queiroz
    Correa Schilithz, Arthur Orlando
    Monteiro, Mariana Costa
    Murad, Leonardo Borges
    Fialho, Eliane
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (04): : 1261 - 1269
  • [30] IMPACT OF RENAL SURGERY ON DEVELOPMENT OF SURGICAL STAGE IV CHRONIC KIDNEY DISEASE AND OVERALL MORTALITY IN PATIENTS WITH STAGE I RENAL CELL CARCINOMA AND WITHOUT PREOPERATIVE RENAL INSUFFICIENCY
    Derweesh, Ithaar H.
    Liss, Michael A.
    Bagrodia, Aditya
    Mehrazin, Reza
    Kopp, Ryan P.
    Bazzi, Wassim M.
    Cohen, Seth A.
    Wake, Robert
    Patterson, Anthony L.
    Wan, Jim Y.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E741 - E741
12345